Background: X-C Motif Chemokine Ligand 2 (XCL2) is a 114 amino acid, structurally conserved chemokine involved in activating cytotoxic T cells. However, the pathophysiological mechanisms of XCL2 protein in various disease conditions, particularly cancer, remain poorly understood.
Methods: Bioinformatics was used to detect the expression of XCL2, the relationship between survival time and XCL2 in BLCA patients, the mutational status of XCL2, the role of XCL2 in the tumor immune microenvironment, and the sensitivity of XCL2-targeted drugs in 33 cancers. experiments were conducted to investigate the chemotactic effects of XCL2 expression on M1-type macrophages in human specimens and in isolated cancer cells.
Results: XCL2 expression was downregulated in tumor tissues and closely associated with the prognosis of human cancers. Furthermore, XCL2 affects DNA methylation, tumor mutation burden (TMB), microsatellite instability (MSI), and mismatch repair (MMR) in human cancers. The expression level of XCL2 significantly correlated with infiltrated immune cells, immunological pathways, and other immune markers. More importantly, we found that XCL2 was positively associated with T lymphocytes and macrophages in the transcriptome and single-cell sequencing data. Using multiple immunofluorescence staining, we found that the expression level of XCL2 was upregulated in many cells in pan-cancer samples, and the number of M1 macrophage marker CD68 and INOS-positive cells increased. 786O, U251, and MDA-MB-231 cells could recruit more M1 macrophages after overexpressing XCL2.
Conclusions: Our results reveal that XCL2 could act as a vital chemokine in pan-cancer and provide new targets and concepts for cancer treatment.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683633 | PMC |
| http://dx.doi.org/10.18632/aging.205156 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The XCL1-XCR1 axis supports intestinal tissue residency and antitumor immunity.
J Exp Med
March 2025
School of Biological Sciences, University of California, San Diego, La Jolla, CA, USA.
Tissue-resident memory T cells (TRM) provide frontline protection against pathogens and emerging malignancies. Tumor-infiltrating lymphocytes (TIL) with TRM features are associated with improved clinical outcomes. However, the cellular interactions that program TRM differentiation and function are not well understood.
View Article and Find Full Text PDFSingle-cell RNA sequencing reveals peripheral immunological features in Parkinson's Disease.
NPJ Parkinsons Dis
October 2024
Institute of Neuroscience, Kunming Medical University, Kunming, 650500, Yunnan, China.
Article Synopsis
- Researchers are studying the immune response in the blood of Parkinson's disease (PD) patients, focusing specifically on natural killer (NK) cells and their role in the disease progression.
- The study used single-cell RNA sequencing to identify different immune cell types in blood samples from both early and late-stage PD patients compared to healthy controls.
- Findings revealed a decline in NK cells as PD progressed, indicating a strong link between the peripheral immune response and the central nervous system, with potential for NK cell-specific biomarkers like XCL2 to assist in diagnosing and monitoring PD.
Cathepsin W, T-cell receptor-associated transmembrane adapter 1, lymphotactin and killer cell lectin like receptor K1 are sensitive and specific RNA biomarkers of canine epitheliotropic lymphoma.
Front Vet Sci
November 2023
Department of Dermatology, UMass Chan Medical School, Worcester, MA, United States.
Article Synopsis
- Cutaneous T-cell lymphoma (CTCL) is a rare lymphoma linked to malignant T cells in the skin, with canine epitheliotropic lymphoma (EL) being the most common form in dogs.
- The study aimed to find new biomarkers to differentiate EL from benign skin conditions and compared gene expression between human CTCL and canine EL using tissue samples from dogs.
- Results showed that certain gene signatures were higher in EL and identified specific biomarkers that could help distinguish it from other skin disorders, potentially aiding in disease prognosis and treatment in veterinary medicine.
Comprehensive analysis reveals XCL2 as a cancer prognosis and immune infiltration-related biomarker.
Aging (Albany NY)
October 2023
Department of Urology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Background: X-C Motif Chemokine Ligand 2 (XCL2) is a 114 amino acid, structurally conserved chemokine involved in activating cytotoxic T cells. However, the pathophysiological mechanisms of XCL2 protein in various disease conditions, particularly cancer, remain poorly understood.
Methods: Bioinformatics was used to detect the expression of XCL2, the relationship between survival time and XCL2 in BLCA patients, the mutational status of XCL2, the role of XCL2 in the tumor immune microenvironment, and the sensitivity of XCL2-targeted drugs in 33 cancers.
Structural and mechanical analysis on mannuronate-rich alginate gels and xerogels beads based on Calcium, Copper and Zinc as crosslinkers.
Int J Biol Macromol
August 2023
Department of Chemical Engineering, Universitat Rovira I Virgili, Av. Països Catalans, 26, 43007 Tarragona, Spain. Electronic address:
Beads based on a mannuronate(M)-rich alginate (86 % M units) were prepared by adding the polysaccharide solution to a crosslinking bath containing different concentrations (0.5, 2 and 10 wt%) of XCl where X = Ca, Cu or Zn. Primarily focus was on Zn, due to its antioxidant, anti-inflammatory and anti-microbial capabilities.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!